Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Salivary caffeine metabolic ratio in alcohol-dependent subjects.

European journal of clinical pharmacology - 1 Apr 2004

Kukongviriyapan Veerapol, Senggunprai Laddawan, Prawan Auemduan, Gaysornsiri Danu, Kukongviriyapan Upa, Aiemsa-Ard Jareerat

Abstract excerpt

OBJECTIVES: To determine whether caffeine (CA) clearance and salivary paraxanthine (PX)/CA ratio were altered in alcohol-dependent subjects and also whether salivary PX/CA ratio was affected by arylamine-N-acetylation 2 ( NAT-2) genotypes. METHODS: Of 30 male individuals recruited in assessing PX...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alcoholism
Share to Arylamine N-Acetyltransferase
Share to Caffeine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP1A2

Share to Liver Diseases

Share to Liver Function Tests

Share to Saliva

Share to Theophylline

Source

Identifiers

PMID: 15022032
DOI: 10.1007/s00228-004-0734-3

Genes

NAT2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-15022032-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Salivary caffeine metabolic ratio in alcohol-dependent subjects.PMID 15022032Read ↗

Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in saliva.Semantic proximity Read ↗

Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlations.Semantic proximity Read ↗

Caffeine and paraxanthine HPLC assay for CYP1A2 phenotype assessment using saliva and plasma.Semantic proximity Read ↗

Analysis of caffeine and paraxanthine in human saliva with ultra-high-performance liquid chromatography for CYP1A2 phenotyping.Semantic proximity Read ↗

Caffeine metabolic ratios for the in vivo evaluation of CYP1A2, N-acetyltransferase 2, xanthine oxidase and CYP2A6 enzymatic activities.Semantic proximity Read ↗

Development and validation of a reversed-phase HPLC method for CYP1A2 phenotyping by use of a caffeine metabolite ratio in saliva.Semantic proximity Read ↗

CYP1A2 in a smoking and a non-smoking population; correlation of urinary and salivary phenotypic ratios.Semantic proximity Read ↗

Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites.Semantic proximity Read ↗

Phenotyping of N-acetyltransferase type 2 and xanthine oxidase with caffeine: when should urine samples be collected?Semantic proximity Read ↗

Unraveling the complexities of caffeine: metabolism, genetics, evolution, and health.Semantic proximity Read ↗

Relationship between antipyrine metabolism and acetylation phenotype in health and chronic liver diseases.Semantic proximity Read ↗

Acetylation phenotypes and biological variation in a French Caucasian population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.